Test Code OROT Orotic Acid, Random, Urine
Reporting Name
Orotic Acid, UUseful For
Evaluation of the differential diagnosis of hyperammonemia and hereditary orotic aciduria
Sensitive indicator of ornithine transcarbamylase (OTC) activity after administration of allopurinol or a protein load to identify OTC carriers
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
UrineNecessary Information
1. Patient's age is required.
2. Provide a reason for testing.
Specimen Required
Supplies: Urine Tubes, 10 mL (T068)
Container/Tube: Plastic, 10-mL urine tube
Specimen Volume: 10 mL
Collection Instructions:
1. Collect a random or timed urine specimen.
2. No preservative needed.
Specimen Minimum Volume
3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Frozen | 30 days |
Reference Values
<2 weeks: 1.4-5.3 mmol/mol creatinine
2 weeks-1 year: 1.0-3.2 mmol/mol creatinine
2-10 years: 0.5-3.3 mmol/mol creatinine
≥11 years: 0.4-1.2 mmol/mol creatinine
Day(s) Performed
Tuesday, Thursday
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
83921
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
OROT | Orotic Acid, U | 17869-9 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
8905 | Orotic Acid, U | 17869-9 |
Interpretation
The value for the orotic acid concentration is reported. The interpretation of the result must be correlated with clinical and other laboratory findings.
Clinical Reference
1. Singh RH, Rhead WJ, Smith W, et al. Nutritional management of urea cycle disorders. Crit Care Clin. 2005;21(4 Suppl):S27-35
2. Lee B, Singh RH, Rhead WJ, et al. Considerations in the difficult-to-manage urea cycle disorder patient. Crit Care Clin. 2005;21(4 Suppl):S19-25
3. Brusilow SW, Horwich AL. Urea cycle enzymes. In: Valle D, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA, eds. The Online Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill; 2019. Accessed January 14, 2024. Available at http://ommbid.mhmedical.com/content.aspx?bookid=2709§ionid=225084071
4. Webster DR, Becroft DO, van Gennip AH, Van Kuilenburg AP. Hereditary orotic aciduria and other disorders of pyrimidine metabolism. In: Valle D, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA, eds. The Online Metabolic and Molecular Bases of Inherited Disease., McGraw-Hill; 2019. Accessed January 14, 2024. Available at http://ommbid.mhmedical.com/content.aspx?bookid=2709§ionid=225090376
5. Ah Mew N, Simpson KL, Gropman AL, Lanpher BC, Chapman KA, Summar, ML. Urea cycle disorders overview. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews [Internet]. University of Washington, Seattle; 2003. Updated June 22, 2017. Accessed January 14, 2024. Available at www.ncbi.nlm.nih.gov/books/NBK1217
Report Available
4 to 8 daysMethod Name
Colorimetric
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.